Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Understanding Vape Counter-Marketing Study

9 de noviembre de 2026 actualizado por: Shivani Gaiha, Boston Children's Hospital

Countering E-Cigarette Marketing in the Retail Environment Among Adolescents and Young Adults

The goal of this interventional study is to test whether short videos of electronic-cigarette (e-cigarette) counter-marketing lessons work to decrease people's intent to use and smoke e-cigarettes. Using short videos, the investigators hope to inform participants about the marketing strategies that e-cigarette companies use to try to get people to purchase and use e-cigarettes. The investigators hope to find that, after watching the short videos, people will be able to point out when e-cigarette companies are trying to sell their products, and hopefully they will have a lower interest in buying and using e-cigarettes. The investigators also hope participants will learn more about the addictiveness and harmfulness of using e-cigarettes by watching the short videos.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Estimado)

2556

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

13 años a 21 años (Niño, Adulto)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • 13-21 years old
  • Fluent in English
  • Owns a smartphone or other device that can be used to complete study activities (e.g., watching videos, responding to electronic surveys)
  • Meets sampling ratio to match the US Census for sex assigned at birth, race, and ethnicity

Exclusion Criteria:

  • Fails survey validation checks (e.g., completing the survey too quickly, providing the same answer to every question)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: New Intervention Group

Participants in this arm will receive a novel intervention developed by the study team.

Participants will view 4 short-form videos filmed by influencers. Influencers convey messaging designed to counter e-cigarette marketing in retail stores.

Comparador activo: Pre-existing Intervention

Participants will receive a comparable, pre-existing intervention not developed by the study team.

Participants will view 1 video in the public domain with messaging on e-cigarette marketing tactics.

Otro: Control Condition

Participants will receive a control condition that was not developed by the study team.

Participants will view 4 short-form influencer-generated videos on topics that are unrelated to counter e-cigarette marketing in retail stores.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Susceptibility to use e-cigarettes among those who never used
Periodo de tiempo: From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).

Susceptibility to use e-cigarettes among those who never used [Susceptibility scores are calculated based on the following 4 items:

  1. Do you think you will try/ use a nicotine vape in the next year?
  2. Do you think that you will try/use a nicotine vape soon?
  3. If one of your best friends were to offer you a nicotine vape, would you try/use it?
  4. Have you ever been curious about trying/using a nicotine vape? Response options for the first three items are: 1 = definitely not, 2 = probably not, 3 = probably yes, and 4 = definitely yes, and for the fourth item were: 1 = not at all curious, 2 = a little curious, 3 = somewhat curious, and 4 = very curious. Per Persoskie and O'Brien (2022), the four items are averaged to create a single index.]

O'Brien EK, Baig SA, Persoskie A. Developing and Validating Measures of Absolute and Relative E-Cigarette Product Risk Perceptions: Single Items Can Be Surprisingly Comprehensive. Nicotine Tob Res. 2022;24(3):316-323. doi:10.1093/ntr/n

From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
E-cigarette Use
Periodo de tiempo: From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
  1. Have you EVER used any of the following products, even one or two puffs

  2. During the PAST 30 DAYS, have you used any of the following products, even one or two puffs?

  3. During the PAST 30 DAYS, on how many days (from 0 days to 30 days) did you use a… (numeric response)

  4. During the PAST 7 DAYS, have you used any of the following products, even one or two puffs?

  5. During the PAST 7 DAYS, on how many days (from 0 days to 7 days) did you use a…

  6. Other questions on age at first use, friend use and family use. All questions relate to the following products:

    • Nicotine vape
    • Some kind of vape (Don't know what was in it)
    • Cigarette
    • Nicotine pouch
From Day 1 (Baseline/Pre-intervention) to Day 31 (One-month follow-up after the treatment).
Intent to use e-cigarettes and cigarettes
Periodo de tiempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

Do participants plan to use e-cigarettes and cigarettes?

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Vaping attitudes and norms
Periodo de tiempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

We will measure people's attitudes and acceptance towards vaping using: Vaping Attitudes Scale (5-point Likert-type; high score: positive attitude) and Mean Vaping Injunctive Norms Scale (3-item)

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Pro-vaping marketing exposure (focused on retail), including marketing receptivity
Periodo de tiempo: From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)

Can people understand and recognize e-cigarette marketing? Does it have an effect on them?

From Day 1 (Baseline/Pre-intervention) Day 31 (One-month follow-up after the treatment)
Marketing exposure on social media
Periodo de tiempo: Day 1 (Baseline/Pre-intervention)

Questions to assess social media use, frequency, and platforms.

Day 1 (Baseline/Pre-intervention)
Anti-vaping content exposure
Periodo de tiempo: Day 1 (Baseline/Pre-intervention)

Prior exposure to having seen content that dissuades people from using vapes and locations where they saw it.

Day 1 (Baseline/Pre-intervention)
Knowledge of e-cigarette retail marketing
Periodo de tiempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

How much do people know about e-cigarette retail marketing (based on key messages and facts shown in video content)?

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Perceived message effectiveness
Periodo de tiempo: Day 1 (Immediately post-intervention)

We will test the effectiveness of the videos using two scales, the Message Assessment Scale for Tobacco Prevention Campaigns, and the Perceived Message Effectiveness Scale (6-item).

Day 1 (Immediately post-intervention)
Video acceptability
Periodo de tiempo: Day 1 (Immediately post-treatment)

We will test how much people enjoyed and connected with the videos based on a quality rating scale and a question on alternative ways to receive content.

Day 1 (Immediately post-treatment)

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Recruitment, enrollment, and attrition
Periodo de tiempo: From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)

We want to measure recruitment and enrollment success, and how many people complete the study.

From Day 1 (Baseline/Pre-intervention); Day 1 (Immediately Post-intervention); and Day 31 (One-month follow-up after the treatment)
Video feasibility
Periodo de tiempo: Day 1 (Immediately post-intervention)

We want to test whether people were able to watch the videos, how many of them they watched and for how long, and what devices they used to watch them.

Day 1 (Immediately post-intervention)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

15 de noviembre de 2026

Finalización primaria (Estimado)

30 de abril de 2027

Finalización del estudio (Estimado)

30 de abril de 2027

Fechas de registro del estudio

Enviado por primera vez

3 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Publicado por primera vez (Actual)

13 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • 26-504
  • R00CA267477 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .